September 19, 2014 10:49 PM ET

Pharmaceuticals

Company Overview of Euclises Pharmaceuticals, Inc.

Company Overview

Euclises Pharmaceuticals, Inc. researches, develops, and commercializes medicines in the field of inflammation and oncology. Euclises Pharmaceuticals, Inc. was formerly known as Talley NewCo, Inc. The company was incorporated in 2011 and is based in St. Louis, Missouri.

4320 Forest Park Avenue

Suite 303

St. Louis, MO 63108

United States

Founded in 2011

Phone:

314-604-2850

Key Executives for Euclises Pharmaceuticals, Inc.

Co-Founder and Director
Age: 65
Co-Founder and Director
Co-Founder
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
HNP Pharmaceuticals United States
Sunovion Pharmaceuticals Inc. United States
TOLMAR Inc. United States
PetMedicus Laboratories, Inc. United States
Clintriad Pharma Services United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 30, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Euclises Pharmaceuticals, Inc., please visit www.euclises.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.